CrystallicX: Engineer crystals your process can handle.

01 / PHASE BEHAVIOR & YIELD

Find a workable route through a complex process landscape.

Some crystallizations have a straightforward operating window. Others involve complex phase behavior, competing solid forms, solvent inclusion or narrow regions in which the desired material is stable. A condition that looks attractive in isolation may be difficult to operate or reproduce.

We evaluate candidate routes and stability regions in the context of the compound, solvent system and available evidence. Cooling, antisolvent addition and solvent-removal strategies are considered together with yield targets, recovery and solid-form requirements. Where the evidence is incomplete, the next experiments are designed to resolve the uncertainty that matters most.

Growth regimes describe what limits the rate at which a crystal grows: transport of solute to the crystal surface, incorporation at the surface, or a combination of both. Common descriptions include diffusion or mass-transfer control, surface-integration control (also described as surface-reaction control), and mixed control. A shift in the limiting step can change how useful a mixing or temperature adjustment will be.

As temperature, composition, mixing or supersaturation change, a process can move between growth regimes. Supersaturation is the driving condition created when dissolved concentration exceeds equilibrium solubility. Different faces can respond differently, changing growth rate and habit even while the polymorph remains the same. Unrecognized transitions can therefore make morphology less predictable. We consider these kinetic regimes alongside phase behavior when assessing a process path: a growth-regime map adds information that an equilibrium phase diagram alone does not provide.

Decision supported: which route and operating region deserve development effort, and what must be confirmed before committing.

02 / PARTICLE SIZE & SHAPE

Design particle attributes around what happens next.

Particle-size distribution (PSD) describes the range and relative abundance of particle sizes, while crystal habit describes external shape. Particle-shape distribution describes the mix of these shapes across the population. A batch with an acceptable average size may still contain fines or long needles that behave differently during filtration and handling. CrystallicX connects these observations of the particle population to millability, suitability for micronization, flowability and the storage or preformulation requirements of the project.

Crystal habit engineering may, for example, investigate a shift from long needles toward shorter rod-like habits while retaining the intended polymorph. Changes to supersaturation management are assessed against these particle targets and solid-form requirements. This is a material-specific development objective, verified with solid-form and particle evidence. The aim is to improve the balance of processability and material performance, rather than optimize size alone.

Decision supported: which particle attributes are worth targeting and how the proposed changes should be evaluated downstream.

03 / STRATEGY & EXPERIMENTAL EVIDENCE

Build the method around the material and your laboratory.

We investigate the combination of crystallization route, seeding point and seed attributes, addition or cooling profiles, and tailored temperature or dissolution–growth cycles. Seed form, loading and size distribution define the starting crystal population and the evidence needed to interpret its subsequent growth. Solvates and channel-solvent inclusion can be incorporated into the problem definition where they affect the desired material.

Projects can use process analytical technology (PAT) where available, or be built around planned sampling and offline measurements. The resulting system can range from a focused theoretical study to experimentally supported method optimization or an automated workflow. The measurement strategy and the development method are designed together.

Decision supported: a practical strategy, evidence plan and operating conditions to evaluate in the next development stage.

04 / MANUFACTURING ISOLATION

Carry the desired material attributes through filtration and drying.

At manufacturing scale, these considerations also matter when isolating the product after a reaction. Active pharmaceutical ingredient (API) isolation turns the crystallization slurry into recovered dry material. Filtration is the solid–liquid separation step that forms a cake; particle size and shape influence filterability. Cake washing helps remove retained mother liquor. Deliquoring removes liquid from the cake before drying reduces the remaining solvent. These operations must be assessed together to preserve the particle and solid-form attributes established upstream.

Particle size, shape and fines influence cake formation, permeability and the retention of liquid. Washing and drying can introduce further changes: dissolution or reprecipitation, agglomeration, crystal breakage and residual-solvent concerns. A desirable slurry can therefore become a difficult filter cake or an inconsistent dry product if these stages are considered separately.

CrystallicX brings isolation constraints into the crystallization development question. We relate the proposed particle target and route to filtration, cake washing, deliquoring and drying evidence, and identify the measurements needed to examine behavior at the intended scale.

Decision supported: an integrated development strategy for material recovery, cake handling and the quality of the isolated product.